BeStock  
Markets › Compare › MNPR vs HELP

MNPR vs HELP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MNPR · Monopar Therapeutics$69.00 ▼ 1.84%
HELP · Cybin$6.11 ▼ 9.88%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4395146198249Nov 24, '25May 26, '26Nov 20, '26
  • MNPR -25.6%
  • HELP +3.7%

Head to head

MetricMNPRHELP
Price$69.00$6.11
Change today▼ 1.84%▼ 9.88%
Market cap$467.60M$487.62M
Return, 3 months-38.0%-53.1%
Return, year to date+5.7%-25.3%
Return, 1 year-24.6%+9.3%
P/E (TTM)––
P/B3.72.0
P/E percentile vs own 5y12th34th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-80.3%-94.3%
Gross margin––
Operating margin––
Net margin––
Return on equity-15.3%-86.9%
Analyst target vs. price+86.5%+573.8%
Analyst buy share100%100%
RSI (14)4024
30-day volatility53.1%89.2%
Max drawdown, 1 year-46.5%-56.4%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • HELP is the largest of the group by market value.
  • HELP has returned the most over the past year.
  • MNPR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top